Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

Historical Holders from Q4 2014 to Q3 2025

Symbol
CTSO on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
65.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
16.3M
Holdings value
$15.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
48
Number of buys
21
Number of sells
-12
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SATTERFIELD THOMAS A JR 6.56% $4.64M 4M Thomas A. Satterfield, Jr. 13 Jan 2025
Avenue Venture Opportunities Fund, L.P. 5.7% $4.36M 3.76M Avenue Capital Management II, L.P. 26 Jun 2024
AVENIR CORP 5.7% $3.59M 3.09M AVENIR CORP 31 Dec 2024
Skylands Capital, LLC 4.8% -6% $3.48M $256K 3M +7.95% Skylands Capital, LLC 31 Mar 2025
VANGUARD GROUP INC 3.11% -57.4% $2.26M -$2.26M 1.95M -50% The Vanguard Group 31 Mar 2025

Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16.3M $15.3M -$76.2K $0.93 48
2025 Q2 16.4M $20.7M -$476K $1.28 43
2025 Q1 16.9M $16.9M +$1.62M $1.00 47
2024 Q4 15.3M $14.1M -$1.26M $0.91 49
2024 Q3 16.5M $24.7M -$164K $1.50 52
2024 Q2 16.5M $11.6M -$649K $0.70 44
2024 Q1 17.6M $16.7M -$484K $0.95 48
2023 Q4 18.1M $20M +$3.22M $1.11 52
2023 Q3 15.2M $28.6M -$153K $1.88 52
2023 Q2 15.2M $54.7M +$138K $3.59 58
2023 Q1 15.2M $51.2M +$1.68M $3.37 57
2022 Q4 14.6M $22.6M -$46K $1.55 47
2022 Q3 13.7M $18.7M -$1.56M $1.36 51
2022 Q2 15.5M $33.9M -$6.12M $2.19 68
2022 Q1 18M $57.5M +$256K $3.19 81
2021 Q4 17.8M $74.5M -$8.09M $4.19 89
2021 Q3 18.4M $149M +$6.98M $8.12 93
2021 Q2 17.5M $132M -$233K $7.55 97
2021 Q1 17.5M $152M -$2M $8.68 91
2020 Q4 17.6M $140M +$3.07M $7.97 89
2020 Q3 17.2M $137M +$46.4M $7.98 94
2020 Q2 11.2M $111M +$14.1M $9.90 89
2020 Q1 9.94M $76.8M +$8.99M $7.73 79
2019 Q4 8.94M $34.4M +$1.51M $3.85 70
2019 Q3 8.44M $42.5M -$1.06M $5.03 66
2019 Q2 8.51M $56.3M +$526K $6.61 68
2019 Q1 8.51M $64.4M -$1.16M $7.57 71
2018 Q4 8.66M $69.9M +$1.13M $8.08 82
2018 Q3 8.2M $106M +$5.08M $12.90 78
2018 Q2 7.8M $88.9M +$45.8M $11.40 72
2018 Q1 3.92M $27.7M +$5.32M $7.05 47
2017 Q4 3.21M $20.8M +$4.72M $6.50 43
2017 Q3 2.48M $15.4M +$3.76M $6.20 30
2017 Q2 1.94M $8.34M -$2.21M $4.30 30
2017 Q1 2.43M $10.9M +$4.44M $4.50 33
2016 Q4 1.59M $8.69M +$49.1K $5.45 37
2016 Q3 1.57M $10M -$1.21M $6.40 34
2016 Q2 1.77M $8.06M +$413K $4.55 33
2016 Q1 1.41M $5.51M +$5.7K $3.92 31
2015 Q4 1.38M $7.66M -$174K $5.57 38
2015 Q3 1.35M $8.51M +$690K $6.30 30
2015 Q2 1.24M $7.63M +$743K $6.14 29
2015 Q1 908K $11.9M +$7.89M $13.19 27
2014 Q4 394K $3.92M +$1.05M $9.96 9